|
|
|
|
LEADER |
01843nam a22004337i 4500 |
001 |
MUB01006506595 |
003 |
CZ BrMU |
005 |
20220819092212.0 |
008 |
220817t19921992xxu||||| |||||||||||eng d |
STA |
|
|
|a POSLANO DO SKCR
|b 2022-09-26
|
020 |
|
|
|a 0-8247-2804-1
|
040 |
|
|
|a BOD037
|b cze
|e rda
|
072 |
|
7 |
|a 615
|x Farmacie. Farmakologie
|2 Konspekt
|9 14
|
080 |
|
|
|a 615:338.45
|2 MRF
|
080 |
|
|
|a (031)
|2 MRF
|
080 |
|
|
|a 615.012/.014
|2 MRF
|
245 |
0 |
0 |
|a Encyclopedia of pharmaceutical technology.
|n Volume 5,
|p Economic characteristics of the R&D-Intensive pharmaceutical industry to fermentation processes /
|c editors James Swarbrick, James C. Boylan
|
264 |
|
1 |
|a New York :
|b Marcel Dekker,
|c [1992]
|
264 |
|
4 |
|c ©1992
|
300 |
|
|
|a xi, 565 stran :
|b schémata
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a bez média
|b n
|2 rdamedia
|
338 |
|
|
|a svazek
|b nc
|2 rdacarrier
|
650 |
0 |
7 |
|a farmaceutická technologie
|7 ph114524
|2 czenas
|
650 |
0 |
7 |
|a farmaceutický průmysl
|7 ph120140
|2 czenas
|
650 |
0 |
9 |
|a pharmaceutical technology
|2 eczenas
|
650 |
0 |
9 |
|a pharmaceutical industry
|2 eczenas
|
655 |
|
7 |
|a encyklopedie
|7 fd132201
|2 czenas
|
655 |
|
9 |
|a encyclopedias
|2 eczenas
|
700 |
1 |
|
|a Swarbrick, James,
|d 1934-2020
|7 mub20221159821
|4 edt
|
700 |
1 |
|
|a Boylan, James C.,
|d 1943-
|7 mub20221159844
|4 edt
|
CAT |
|
|
|a BACOVSKA
|b 02
|c 20220817
|l MUB01
|h 1302
|
CAT |
|
|
|a BACOVSKA
|b 02
|c 20220817
|l MUB01
|h 1312
|
CAT |
|
|
|a VASICEKX
|b 02
|c 20220819
|l MUB01
|h 0922
|
CAT |
|
|
|c 20220926
|l MUB01
|h 1128
|
LOW |
|
|
|a POSLANO DO SKCR
|b 2022-09-26
|
994 |
- |
1 |
|l MUB01
|l MUB01
|m BOOK
|1 KUK
|a Knihovna univ. kampusu
|2 UFTE
|b FAF: Ústav farmaceutické technologie
|9 611.55-ENCY
|5 3307000799
|4 DISP.: UFTE
|8 20220817
|f 78
|f Mimo UK
|r 20220817
|s převod
|
AVA |
|
|
|a MED50
|b KUK
|c FAF: Ústav farmaceutické technologie
|e available
|t K dispozici
|f 1
|g 0
|h N
|i 0
|j UFTE
|